Skip to content

Application of cyclopropofol combined with LiDCO hemodynamic monitoring in robotic pelvic fracture surgery

Application of cyclopropofol combined with LiDCO hemodynamic monitoring in robotic pelvic fracture surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069786
Enrollment
Unknown
Registered
2023-03-25
Start date
2023-03-22
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia in infertile patients undergoing hysteroscopy

Interventions

Group propofol:Propofol was induced and maintained+routine monitoring
Group one of ciprofol:Ciprofol was induced and maintained+routine monitoring
Group two of ciprofol:Ciprofol was induced and maintained+LiDCO monitoring

Sponsors

The First Affiliated Hospital of University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Robot-assisted minimally invasive internal fixation of pelvic fractures was planned; 2.ASA I-? grade; 3. No history of serious cardiovascular and cerebrovascular diseases, COPD, active mental diseases and blood system diseases; 4. Body mass index (BMI) 18-30 kg/m2.

Exclusion criteria

Exclusion criteria: 1.The operation was converted to open reduction and internal fixation. 2.The patient was multiple injuries, and this operation was combined with other operations. 3.Severe cardiovascular disease, severe respiratory disease, long-term use of psychotropic drugs and cognitive impairment; 4.History of drug abuse, drug abuse, alcohol abuse; 5.Active mental illness; 6.Allergic or contraindicated to opioids, propofol and other drugs and their components.

Design outcomes

Primary

MeasureTime frame
BIS values;Invasive Blood pressure;heart rate;Oxygen saturation;Recovery time;the postoperative length of stay;Stroke volume variation;Stroke volume;Cardiac function index;

Secondary

MeasureTime frame
Duration of anesthesia;Time of operation;the intraoperative bleeding volume;Fluid replacement volume;Hospitalization expenses;Special intraoperative situations;Use of vasoactive agents;

Countries

China

Contacts

Public ContactChaoliang Tang

The First Affiliated Hospital of University of Science and Technology of China

chaolt@ustc.edu.cn13866777142

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026